How to Get Retatrutide: Clinical Trials and Expanded Access Are the Only Lawful Routes

Understanding what retatrutide is

Before we get into how to access retatrutide, here's what you're actually trying to get. Retatrutide (LY3437943) is an investigational triple hormone receptor agonist developed by Eli Lilly. Unlike semaglutide (GLP-1 only) and tirzepatide (GLP-1 + GIP), retatrutide activates three receptors: GLP-1, GIP, and glucagon.

In Phase 2 trials, participants lost an average of 24.2% of their body weight at 48 weeks on the 12mg dose, the highest weight loss ever recorded for any GLP-1 class medication. The glucagon receptor component appears to add energy expenditure and fat oxidation beyond what GLP-1 and GIP provide alone.

Why people are looking for retatrutide now

If retatrutide won't be FDA-approved for another year or two, why is "how to get retatrutide" one of the fastest-growing searches in the GLP-1 space?

The data is public and impressive

The Phase 2 results, published in the New England Journal of Medicine in June 2023, showed large weight loss results, though no head-to-head trial has compared retatrutide with approved obesity medications. That is why people who've plateaued on semaglutide or tirzepatide, or who need more weight loss for health reasons, are interested in it.

The grey market filled the gap

Research peptide vendors started offering retatrutide within months of the Phase 2 publication. Some telehealth companies and compounders followed, even though the FDA states retatrutide cannot be used in compounding under federal law. The FDA has since warned telehealth companies for marketing retatrutide.

Communities built knowledge bases

Reddit communities like r/Peptides and r/retatrutide, peptide forums, and private groups developed protocols, vendor lists, and safety practices. People weren't waiting for FDA approval. They figured it out themselves, documented what worked, and shared the information.

This guide covers the three options people ask about: clinical trials (the main lawful route, alongside Lilly's narrow expanded access program), compounding pharmacies (not a lawful route for retatrutide), and research peptides (the most common, and not legal or safe to rely on). Each has different cost, risk, and legal profiles.

Route 1: Clinical trials (free, pharmaceutical-grade, medically supervised)

In the US, the routes available today are a clinical trial or Lilly's expanded access program (covered at the end of this section). Most retatrutide Phase 3 trials are no longer enrolling; check ClinicalTrials.gov for open studies. You get pharmaceutical-grade medication for free, full medical supervision, and contribute to the research that will determine whether the drug gets approved.

What the TRIUMPH trials include

• Free study medication: You receive either retatrutide or placebo (trials are randomized). Roughly 2/3 of participants get active drug, 1/3 get placebo.
• Medical monitoring: Regular visits, blood work, vitals, body composition analysis, and side effect tracking
• Compensation: Most trials pay for your time and travel, typically $50-150 per visit depending on location
• Duration: Most trials run 72 weeks (about 18 months) with follow-up visits

Current TRIUMPH trials

How to find and enroll in a trial

Pros and cons of the clinical trial route

This is the route I'd recommend if you qualify. The medication is free, the quality is guaranteed, and you have medical oversight. The main tradeoff is the placebo risk and the time commitment. If those aren't dealbreakers, start here.

The other lawful route: Lilly's expanded access program

Lilly also runs an expanded access program for retatrutide before FDA approval, "for a limited number of patients who meet specific medical criteria and cannot enroll in a clinical trial" (Reuters via KSL). To qualify, a patient must be 18 or older with a BMI of 35 or more despite tolerating the highest available dose of weight-management therapy, have two or more serious or life-threatening obesity-related complications, be unable to join an ongoing retatrutide (or comparable) trial, and have discussed all standard treatment options, including bariatric surgery, with their doctor (Lilly Medical; ClinicalTrials.gov NCT07629401). Patients cannot apply or buy it themselves. The treating physician applies to the FDA as the sponsor of a patient-specific investigational new drug (IND) application and must obtain institutional review board (IRB) approval. Lilly provides the drug at no cost, and direct-to-patient shipping is not available.

Route 2: Compounding pharmacies (not a lawful route for retatrutide)

Some telehealth platforms and compounders have offered compounded retatrutide, but this is not a lawful way to get it. The FDA states that "Retatrutide and cagrilintide cannot be used in compounding under federal law" (FDA). That means compounding pharmacies, whether 503A or 503B, cannot lawfully supply it, with or without a prescription.

The FDA has also warned telehealth companies for marketing retatrutide, API distributors for selling it to compounders, and outsourcing facilities for repackaging it. If a provider or pharmacy offers you compounded retatrutide, it is not a legal product.

Route 3: Research peptides (no prescription, unapproved, buyer beware)

This is the most common route people use to access retatrutide. Research peptide vendors sell retatrutide as "not for human consumption," but the FDA calls these illegally sold unapproved drugs falsely labeled "for research purposes." No prescription is required. Quality varies wildly. Outside a clinical trial or Lilly's expanded access program, you're self-experimenting with an unapproved compound.

How the research peptide market works

Most research-grade retatrutide is synthesized by peptide manufacturers in China. These labs produce bulk powder, which vendors worldwide buy, vial, label, and resell. Some vendors operate domestically (US, EU) and charge more for local handling and faster shipping. Others sell direct from overseas at lower prices but with longer shipping and customs risk.

Typical pricing (research peptides)

*Weeks of supply depends entirely on your dose. At 1mg/week (starting dose), a 5mg vial lasts 5 weeks. At 12mg/week (maximum), it lasts less than half a week. **Monthly cost assumes typical maintenance doses of 4-12mg/week.

Finding vendors

There's no official marketplace. People find sources through:

• Reddit communities: r/Peptides and r/retatrutide discuss experiences and safety but are strict about sourcing. Vendor discussion is largely banned and redirected to external forums
• Peptide forums: Longstanding forums like PeptidesUK, UGBB, and others maintain vendor lists and test databases
• Word of mouth: Private groups and direct recommendations from people who've tested a source
• Group buys: Communities organize bulk purchases to reduce per-vial cost and split third-party testing fees

Vetting vendors and verifying quality

The peptide community has built its own quality control system. The standard practice is third-party testing: you send a sample to an independent lab for HPLC and mass spectrometry analysis. Results show purity percentage, confirm the compound identity, and flag contaminants.

How to verify quality

1. Check for test results: Reputable vendors share third-party test results (usually from Janoshik or similar labs) for each batch. If a vendor has no test results, that's a red flag.
2. Test it yourself: Send a sample to Janoshik (janoshik.com) for HPLC testing (~$120 per test). This confirms purity, dosage accuracy, and compound identity.
3. Check community feedback: Search Reddit and peptide forums for the vendor name. Look for multiple independent test results, not just vendor-posted COAs.
4. Start with small orders: Don't buy 6 months of supply from an unvetted vendor. Order one vial, test it, then scale up if it passes.
5. Watch for red flags: No test results, no customer reviews, too-good-to-be-true pricing, poor communication, or refusal to answer questions about sourcing.

What you'll need to get started

If you go the research peptide route, here's what you'll need to purchase separately:

• Bacteriostatic water: For reconstituting lyophilized powder (~$5-10 per vial)
• Insulin syringes: 0.3mL or 0.5mL with 31G needles (~$15 for 100 syringes)
• Alcohol wipes: For vial tops and injection sites (~$5 for 100)
• Sharps container: For safe needle disposal (~$10)

For step-by-step instructions on reconstitution, see our retatrutide reconstitution guide. Use the reconstitution calculator to determine how many units to draw for your target dose.

Pros and cons of research peptides

Research peptides are the cheapest and most accessible route, but you're trading cost for risk. This is the route most people are actually using, especially those who've been on grey-market semaglutide or tirzepatide before. If you go this route, budget for third-party testing and don't skip the due diligence.

What you need to know before starting retatrutide (any source)

Regardless of which route you choose, here's what you should know before your first injection:

Dosing and titration

The Phase 2 trial protocol started at 2mg/week and escalated every 4 weeks: 2mg → 4mg → 8mg → 12mg. Many people using retatrutide outside of trials start at 1mg/week to minimize side effects and titrate more slowly. For detailed protocols, see our retatrutide dosing guide. A slower approach is covered in our microdosing retatrutide guide.

Side effects

Retatrutide's side effect profile is similar to other GLP-1 medications: nausea, diarrhea, constipation, fatigue, and decreased appetite. These are dose-dependent and usually improve after a few weeks at each dose level. For detailed management strategies, see our retatrutide side effects guide.

Contraindications

Do not use retatrutide if you have:

• Personal or family history of medullary thyroid cancer (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN2)
• History of pancreatitis
• Severe gastroparesis or GI motility disorders
• Pregnancy or trying to conceive (stop retatrutide 2 months before attempting pregnancy)

Reconstitution and storage

If you're using lyophilized (freeze-dried) retatrutide, you'll need to reconstitute it with bacteriostatic water. Store lyophilized powder at 2-8°C (refrigerator) or -20°C (freezer). Once reconstituted, store at 2-8°C and use within 28 days. For step-by-step instructions, see our retatrutide reconstitution guide.

Monitoring and bloodwork

If you're not in a clinical trial, you won't have built-in medical monitoring. Consider getting baseline and periodic blood work to track:

• A1C (if you have prediabetes or diabetes)
• Fasting glucose
• Lipid panel (cholesterol, triglycerides)
• Liver enzymes (ALT, AST)
• Kidney function (creatinine, eGFR)
• Thyroid function (TSH) if you notice symptoms

Most primary care doctors will order these tests if you explain you're using a weight loss medication and want to monitor for side effects. You can also use direct-to-consumer lab services like Quest or LabCorp.

Legal and safety considerations

Is it legal to use retatrutide?

The legality varies by route and jurisdiction:

• Clinical trials: Fully legal. You're participating in an FDA-authorized research study.
• Expanded access: Lawful, but narrow. Lilly's program is requested by a treating physician for patients who meet strict medical criteria and cannot join a trial.
• Compounded retatrutide: Not lawful. The FDA states retatrutide cannot be used in compounding under federal law, so no 503A or 503B pharmacy or telehealth compounder can lawfully supply it, with or without a prescription.
• Research peptides: Not a legal source. The FDA has warned companies that illegally sold retatrutide falsely labeled "for research purposes" or "not for human consumption." It's not regulated, and if customs intercepts an international shipment, they may seize it.

The practical reality: clinical trials and Lilly's narrow expanded access program are the lawful ways to receive retatrutide in the US before approval. Any other source carries legal risk, and there's no legal protection if something goes wrong.

Country-specific considerations

What happens when retatrutide gets FDA approval?

When Eli Lilly gets FDA approval (expected 2027-2028), retatrutide will be available at retail pharmacies with a standard prescription. At that point:

• Insurance may cover it: Coverage will depend on the approved indication (diabetes vs obesity) and your insurance plan. Most diabetes indications get covered; obesity coverage is inconsistent.
• Manufacturer savings programs: Eli Lilly offers savings cards for Mounjaro and Zepbound; whether a similar program will exist for retatrutide, and at what price, has not been announced.
• Compounding: The FDA currently states retatrutide cannot be used in compounding under federal law. See our compounded retatrutide explainer for details.
• List price will be high: Expect $1,000-1,500/month list price based on comparable medications. Without insurance or savings programs, it's expensive.

For more on projected pricing, see our retatrutide cost guide. For FDA timeline details, see our FDA approval status article.